Clinical trial
A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.
NCT00234455 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00234455 |
|---|---|
| Title | A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. |
| Official title | An Evaluation of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With Bifurcation Lesions. |
| Acronym | BIFURCATION |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | drug eluting-stent, drug-eluting stent |
| Enrollment | 86 |
| Start date | Jun 1, 2001 |
| Primary completion | Oct 1, 2002 |
| Completion | Apr 1, 2007 |
| First posted | Oct 7, 2005 |
| Last update posted | Apr 30, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: